These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 25003612)

  • 1. Pre-eclampsia part 2: prediction, prevention and management.
    Chaiworapongsa T; Chaemsaithong P; Korzeniewski SJ; Yeo L; Romero R
    Nat Rev Nephrol; 2014 Sep; 10(9):531-40. PubMed ID: 25003612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic model to guide decision-making on timing of delivery in late preterm pre-eclampsia: the PEACOCK prospective cohort study.
    Duhig K; Seed PT; Placzek A; Sparkes J; Gill C; Brockbank A; Shennan A; Thangaratinam S; Chappell LC
    Health Technol Assess; 2021 May; 25(30):1-32. PubMed ID: 34024312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.
    Hund M; Allegranza D; Schoedl M; Dilba P; Verhagen-Kamerbeek W; Stepan H
    BMC Pregnancy Childbirth; 2014 Sep; 14():324. PubMed ID: 25230734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
    Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD
    Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.
    Yliniemi A; Nurkkala MM; Kopman S; Korpimaki T; Kouru H; Ryynanen M; Marttala J
    Metabolism; 2015 Apr; 64(4):521-6. PubMed ID: 25633269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-eclampsia.
    Sibai B; Dekker G; Kupferminc M
    Lancet; 2005 Feb 26-Mar 4; 365(9461):785-99. PubMed ID: 15733721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of biomarkers for the prediction of pre-eclampsia in women with type 1 diabetes mellitus: A systematic review.
    Wotherspoon AC; Young IS; McCance DR; Holmes VA
    J Diabetes Complications; 2016 Jul; 30(5):958-66. PubMed ID: 26900097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.
    Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?].
    de Moreuil C; Fauchais AL; Merviel P; Tremouilhac C; Le Moigne E; Pasquier E; Pan-Petesch B; Lacut K
    Rev Med Interne; 2018 Dec; 39(12):935-941. PubMed ID: 29933972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New directions in the prediction of pre-eclampsia.
    Kane SC; Da Silva Costa F; Brennecke SP
    Aust N Z J Obstet Gynaecol; 2014 Apr; 54(2):101-7. PubMed ID: 24358966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: The PEACOCK study.
    Duhig KE; Seed PT; Placzek A; Sparkes J; Hendy E; Gill C; Brockbank A; Shennan AH; Thangaratinam S; Chappell LC
    Pregnancy Hypertens; 2021 Jun; 24():90-95. PubMed ID: 33770588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?
    Myatt L; Clifton RG; Roberts JM; Spong CY; Wapner RJ; Thorp JM; Mercer BM; Peaceman AM; Ramin SM; Carpenter MW; Sciscione A; Tolosa JE; Saade G; Sorokin Y; Anderson GD;
    BJOG; 2013 Sep; 120(10):1183-91. PubMed ID: 23331974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added prognostic value of longitudinal changes of angiogenic factors in early-onset severe pre-eclampsia: a prospective cohort study.
    Peguero A; Fernandez-Blanco L; Mazarico E; Benitez L; Gonzalez A; Youssef L; Crispi F; Hernandez S; Figueras F
    BJOG; 2021 Jan; 128(2):158-165. PubMed ID: 32593222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pre-eclampsia-related complications in women with suspected or confirmed pre-eclampsia: development and internal validation of clinical prediction model.
    Saleh L; Alblas MM; Nieboer D; Neuman RI; Vergouwe Y; Brussé IA; Duvekot JJ; Steyerberg EW; Versendaal HJ; Danser AHJ; Meiracker AHVD; Verdonk K; Visser W
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):698-704. PubMed ID: 33030757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
    Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
    Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-eclampsia screening in the first trimester - preemptive action to prevent the peril.
    Vikraman SK; Elayedatt RA
    J Matern Fetal Neonatal Med; 2022 May; 35(9):1808-1816. PubMed ID: 32434399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies.
    Tramontana A; Pablik E; Stangl G; Hartmann B; Dieplinger H; Hafner E
    Placenta; 2018 Feb; 62():9-15. PubMed ID: 29405972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.